| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |